CB
Therapeutic Areas
DYSIS Medical Pipeline
| Drug | Indication | Phase |
|---|---|---|
| DYSIS Colposcope with DYSISmap™ | Cervical cancer screening and diagnosis; Detection of Cervical Intraepithelial Neoplasia (CIN) | Commercial |
Leadership Team at DYSIS Medical
HM
Hailey MacNear
MD, Sacramento Women's Health (Clinical User/Advocate)
EL
Eliot L. Birnbaum
MD, Saratoga Hospital Medical Group (Clinical User/Advocate)
JM
Jackie Martin
DNP, HerMD Cincinnati (Clinical User/Advocate)
JM
Jeffrey M. Thurston
MD, FACOG, Walnut Hill Obstetrics & Gynecology Associates (Clinical User/Advocate)
SA
Sally Abbott
Lead Colposcopist, Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust (Clinical User/Advocate)
JL
Jeff Livingston
MD, FACOG, MacArthur Medical Group, Irving, TX (Clinical User/Advocate)
AL
Adrienne L. Ray
MD, FACOG, Nye Partners, Chicago (Clinical User/Advocate)
PC
Pluvio Coronado
MD, Hospital Clinico San Carlos, Madrid (Clinical User/Advocate)
SL
Simon Leeson
Consultant Gynaecologist, Clinical Director, Cervical Screening Wales (Clinical User/Advocate)
GL
Gemma Lowe
BSCCP-Accredited Nurse Colposcopist, Bedford Hospital NHS Trust, UK (Clinical User/Advocate)